Join

Compare · BTI vs RGC

BTI vs RGC

Side-by-side comparison of British American Tobacco Industries p.l.c. (BTI) and Regencell Bioscience Holdings Limited (RGC): market cap, price performance, sector, and recent activity on the wire.

Summary

  • Both BTI and RGC operate in Medicinal Chemicals and Botanical Products (Health Care), so they compete in similar markets.
  • BTI is the larger of the two at $128.29B, about 8.9x RGC ($14.45B).
  • Over the past year, BTI is up 35.8% and RGC is up 1749.9% - RGC leads by 1714.2 points.
  • BTI has been more active in the news (6 items in the past 4 weeks vs 1 for RGC).
  • BTI has more recent analyst coverage (14 ratings vs 0 for RGC).
PerformanceBTI+35.78%RGC+1749.94%
2025-05-01+0.00%2026-04-30
MetricBTIRGC
Company
British American Tobacco Industries p.l.c.
Regencell Bioscience Holdings Limited
Price
$58.80+2.37%
$30.27+5.49%
Market cap
$128.29B
$14.45B
1M return
+0.53%
+18.78%
1Y return
+35.78%
+1749.94%
Industry
Medicinal Chemicals and Botanical Products
Medicinal Chemicals and Botanical Products
Exchange
NYSE
NASDAQ
IPO
1998
2021
News (4w)
6
1
Recent ratings
14
0
BTI

British American Tobacco Industries p.l.c.

British American Tobacco p.l.c. provides tobacco and nicotine products to consumers worldwide. It offers vapour products, tobacco heating products, and modern oral products; combustible products; and traditional oral products, such as Swedish-style snus and American moist snuff. The company distributes its products to retail outlets. British American Tobacco p.l.c. was founded in 1902 and is based in London, the United Kingdom.